Keating Ashley M. 4
4 · Medpace Holdings, Inc. · Filed Feb 28, 2024
Insider Transaction Report
Form 4
Keating Ashley M.
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2024-02-26$54.99/sh+500$27,495→ 500 total - Sale
Common Stock
[F1]2024-02-26$403.89/sh−246$99,358→ 254 total - Sale
Common Stock
[F1]2024-02-26$404.68/sh−254$102,789→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2024-02-26−500→ 972 totalExercise: $54.99Exp: 2026-05-17→ Common Stock (500 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- [F2]The option vested in full on May 14, 2020.
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Ashley M. Keating|2024-02-28